US sanctions have profoundly affected Cuba's healthcare and economy, prompting the nation to seek stronger biotech collaborations with India, according to Cuban neuroscientist Mitchell Valdes-Sosa.
Valdes-Sosa emphasized that the long-standing US sanctions have created significant hurdles for Cuba's healthcare system, including challenges in importing essential supplies and sustaining public health services. He noted that the sanctions have directly contributed to worsening health indicators, such as an increase in the infant mortality rate, which rose from approximately 5.5 to nearly 10 per 1,000 births over recent years.
In light of these challenges, Valdes-Sosa expressed Cuba's interest in partnering with India, which is recognized for its advanced biomedical and biotechnology research capabilities. He highlighted the potential for collaborative product development, particularly in vaccine and neuroscience research, leveraging India's extensive reach in the pharmaceutical sector.
Valdes-Sosa also mentioned Cuba's robust network of 36 biotechnology and research centers, focusing on areas like genetic engineering and immunology. He underscored the importance of collaboration with Indian scientists to enhance innovation. Furthermore, he praised India's Vaccine Maitri initiative, noting that Cuba has reaped benefits from Indian vaccines, reinforcing the significance of international partnerships in overcoming local healthcare challenges.